

Tocilizumab After Ultra-Short Course Steroids Promising for Newly Diagnosed GCA

FDA Approves Tocilizumab to Treat Systemic Sclerosis-Associated ILD

Late-Breaking Abstract Session Spans the Realm of Drug-Related Research
Tocilizumab Fails Late-Stage Trial for COVID-19
Tocilizumab Fails to Help COVID-19 Patients in Italian Study

Pharmacy Team Combats COVID-19 in NYC: Q&A with Mark J. Sinnett, PharmD, FASHP
Sarilumab Trial Data Shows It May Only Help Critical COVID-19 Patients

New Processes May Stick Around After the Pandemic: Q&A with Wendy Ramey, BSPharm, RPh, CSP

Tocilizumab Begins Clinical Trial for COVID-19
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 7
- Next Page »